Inoxiphin 250 mg, 500 mg, 1 g, 2g Powder for Solution for Injection
PDF Leaflet Revision Date: 28 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible organisms.
Dosage (summary)
Adults: 1-2 g once daily; severe cases: up to 4 g once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; excreted in breast milk, caution advised.
Key Drug Interactions
- Calcium-containing products
- Oral anticoagulants
- Aminoglycosides
Contraindications
- Hypersensitivity to ceftriaxone
- Premature neonates
- Full-term neonates with hyperbilirubinaemia
Common side effects
- Diarrhoea
- Rash
- Eosinophilia
- Leucopenia
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with calcium solutions
- Report any unusual symptoms
Serious warnings
- Serious hypersensitivity reactions
- Severe cutaneous adverse reactions
- Risk of biliary precipitation
Important Disclaimer
The Inoxiphin 250 mg, 500 mg, 1 g, 2g Powder for Solution for Injection professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
